← Leaderboards
Lynn Alexandra Jansen
New York Medical College
$1,535,663
Attributed
$1,535,663
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $287K · FY2008–16$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,535,663 · 2
By mechanism
R01$1,242,097 · 1
R21$293,566 · 1
Top collaborators
No co-investigators on record.
Most similar at New York Medical College
Same institution · by research overlap
- Alison Anne McCormick$2,896,419
- Paul Michael Arnaboldi$5,503,528
- Joseph M Miano$20,018,004
- Michael Balazy$2,529,620
- Fabio A Recchia$8,801,204
Others in their field
Top investigators on “Risk-Benefit Assessment”
- David Jonathan Brenner · Columbia University Health Sciences$33,702,075
- Michael Rutledge Debaun · Vanderbilt University Medical Center$20,652,240
- Katherine L. Wisner · Case Western Reserve University$5,836,699
- Jennifer F Friedman · Rhode Island Hospital$4,032,061
- Andrew T Chan · Massachusetts General Hospital$3,841,054
- Stephen Francis Kingsmore · Rady Pediatric Genomics & Systems Medicine Institute$3,593,706
Research focus
Risk-Benefit AssessmentSocialOncologyPersonsPrevalenceResearch PersonnelMalignant NeoplasmsExpectationParticipantOptimismPredispositionConsentBenefits And RisksReportingClinical ResearchAffectiveEnrollmentClinical TrialsEthicistsCognitiveInformed ConsentEventExhibitsPsychological Factors
Grant awards (8)
Understanding Therapeutic Optimism and its Impact on Risk-Benefit Assessment$199,227
R01 · FY2016 · CA · contact PI
Understanding Therapeutic Optimism and its Impact on Risk-Benefit Assessment$287,033
R01 · FY2015 · CA · contact PI
Understanding Therapeutic Optimism and its Impact on Risk-Benefit Assessment$236,445
R01 · FY2014 · CA · contact PI
Understanding Therapeutic Optimism and its Impact on Risk-Benefit Assessment$234,950
R01 · FY2013 · CA · contact PI
Understanding Therapeutic Optimism and its Impact on Risk-Benefit Assessment$284,442
R01 · FY2012 · CA · contact PI
Understanding Optimism in Clinical Research$132,595
R21 · FY2009 · CA · contact PI
Understanding Optimism in Clinical Research$14,258
R21 · FY2009 · CA · contact PI
Understanding Optimism in Clinical Research$146,713
R21 · FY2008 · CA · contact PI